Facebook Twitter YouTube SoundCloud RSS
 

AstraZeneca Under Scrutiny Again as Countries Spend Billions on Questionable Vaccine

Another AstraZeneca vaccine trial participant alleges serious injury, but the vaccine is still a favorite with the Gates Foundation and developing countries.


By
Jeremy Loffredo